logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2019 — Expert commentary: tackling the treatment options in triple negative metastatic breast cancer

As the number of molecular signatures increases, the choice of the right treatment for the right patient becomes a real challenge.